'On consolidated basis
Quarter ended June 2025 compared with Quarter ended June 2024.
Net sales (including other operating income) of Divis Laboratories has increased 13.79% to Rs 2410 crore. Operating profit margin has jumped from 29.37% to 30.25%, leading to 17.20% rise in operating profit to Rs 729.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 41.38% to 40.99%. Employee cost increased from 13.53% to 13.80%. Other expenses fell from 16.27% to 15.63%.
Other income rose 50.63% to Rs 119 crore. PBIDT rose 20.97% to Rs 848 crore. Provision for interest remained nil.
PBDT rose 20.54% to Rs 845 crore. Provision for depreciation rose 15.46% to Rs 112 crore.
Profit before tax grew 21.36% to Rs 733.00 crore. Share of profit/loss were nil in both the periods. Provision...
Pleaselogin & subscribe to view the full report.
More Reports
|
|